White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

Yassaee, Vahid R., Zeinali, Sirous, Harirchi, Iraj, Jarvandi, Soghra, Mohagheghi, Mohammad A., Hornby, David P. and Dalton, Ann (2002) Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Research, 4 (4). ISSN 1465-542X

Full text available as:
[img]
Preview
Text
bcr443.pdf

Download (459Kb)

Abstract

BACKGROUND:

Breast cancer is the most common female malignancy and a major cause of death in middle-aged women. So far, germline mutations in the BRCA1 and BRCA2 genes in patients with early-onset breast and/or ovarian cancer have not been identified within the Iranian population.

METHODS:

With the collaboration of two main centres for cancer in Iran, we obtained clinical information, family history and peripheral blood from 83 women under the age of 45 with early-onset breast cancer for scanning of germline mutations in the BRCA1 and BRCA2 genes. We analysed BRCA1 exons 11 and BRCA2 exons 10 and 11 by the protein truncation test, and BRCA1 exons 2, 3, 5, 13 and 20 and BRCA2 exons 9, 17, 18 and 23 with the single-strand conformation polymorphism assay on genomic DNA amplified by polymerase chain reaction.

RESULTS:

Ten sequence variants were identified: five frameshifts (putative mutations – four novel); three missense changes of unknown significance and two polymorphisms, one seen commonly in both Iranian and British populations.

CONCLUSIONS

Identification of these novel mutations suggests that any given population should develop a mutation database for its programme of breast cancer screening. The pattern of mutations seen in the BRCA genes seems not to differ from other populations studied. Early-onset breast cancer (less than 45 years) and a limited family history is sufficient to justify mutation screening with a detection rate of over 25% in this group, whereas sporadic early-onset breast cancer (detection rate less than 5%) is unlikely to be cost-effective.

Item Type: Article
Copyright, Publisher and Additional Information: © 2002 Yassaee et al., licensee BioMed Central Ltd
Keywords: BRCA1, BRCA2, breast cancer, Iranian population, mutation detection methods
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biological Sciences (Sheffield) > Department of Molecular Biology and Biotechnology (Sheffield)
Depositing User: Repository Officer
Date Deposited: 19 Jul 2004
Last Modified: 08 Feb 2013 16:46
Published Version: http://breast-cancer-research.com/content/4/4/R6
Status: Published
Refereed: Yes
Identification Number: 10.1186/bcr443
URI: http://eprints.whiterose.ac.uk/id/eprint/20

Actions (login required)

View Item View Item